SCHEMBL7983114

SCHEMBL7983114

NC(=O)N(c1ccc(Cl)c(Cl)c1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
EPHX1 P07099 1/20 0.39
EPHX2 P34913 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
BCAT2 O15382 1/20 0.39
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
APEX1 P27695 1/20 0.38
ALDH1A1 P00352 2/20 0.38
IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29504742 0.93 NPC1 (0.42) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL337227 0.93 NPC1 (0.42) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL4353102 0.87 HSD17B10 (0.41) TSHRHSD17B10CYP3A4ALDH1A1IDO1
SCHEMBL11851274 0.82 F13A1 (0.43) HDAC3HDAC1HDAC2HDAC6CYP3A4
SCHEMBL11810698 0.82 TSHR (0.41) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL11262864 0.82 TSHR (0.41) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL1879907 0.81 ALDH1A1 (0.42) TSHREPHX1EPHX2HSD17B10CYP3A4
SCHEMBL526256 0.80 TSHR (0.39) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL11398672 0.80 APEX1 (0.43) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL1304561 0.78 PPARA (0.52) TSHRCYP3A4ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108863852-A A kind of addition method of new diuron 安徽广信农化股份有限公司 2018-11-23 CN disclosed
CN-104496855-B Method for preparing diuron 山东润博生物科技有限公司 2017-02-22 CN disclosed
WO-2015095202-A2 ACTIVATORS OF MYOSIN II FOR MODULATING CELL MECHANICS THE JOHNS HOPKINS UNIVERSITY (US) 2015-06-25 WO disclosed
CN-104496855-A Method for preparing diuron SHANDONG RUNBO BIOTECHNOLOGY CO LTD 2015-04-08 CN disclosed
WO-2013155047-A2 COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR TRUSTEES OF DARTMOUTH COLLEGE (US) 2013-10-17 WO disclosed
WO-2012103523-A2 NOVEL MODULATORS OF DEVELOPMENT OF ADIPOCYTE AND CANCER CELLS RAHBAR SAMUEL (US) 2012-08-02 WO disclosed
US-6281240-B1 CYSTIC FIBROSIS ELI LILLY AND COMPANY 2001-08-28 US disclosed
WO-1998044799-A1 DIARYLSULFONYLUREAS FOR USE IN TREATING SECRETORY DIARRHEA ELI LILLY AND COMPANY (US) 1998-10-15 WO disclosed
EP-0555036-B1 Antitumor compositions and methods of treatment LILLY CO ELI (US) 1998-09-09 EP disclosed
EP-0583960-B1 Synthesis of bicyclic aromatic sulfonic acids, sulfonyl chlorides and sulfonamides LILLY CO ELI (US) 1997-05-21 EP disclosed
EP-0606723-A1 Imidazolidin-2-one derivatives and their use as antitumor agents ELI LILLY AND COMPANY (US) 1994-07-20 EP disclosed
EP-0583960-A2 Synthesis of bicyclic aromatic sulfonic acids, sulfonyl chlorides and sulfonamides ELI LILLY AND COMPANY (US) 1994-02-23 EP disclosed
US-5270329-A 1-arylsulfonyl-imidazolidin-2-one derivatives ELI LILLY AND COMPANY (US) 1993-12-14 US disclosed
US-5254582-A Using n-((3,4-dichlorophenyl)amino)carbonyl)-2,3-dihydro-benzofuran-5-sulfonamide ELI LILLY AND COMPANY (US) 1993-10-19 US disclosed
EP-0555036-A2 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1993-08-11 EP disclosed